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EXPERIMENTAL AND CLINICAL NEPHROSIS*
J. M . BANDERA, M.D., J. M . O ' N E I L L ,

M.D.,

AND GORDON

MANSON,

M.D.

DR. MANSON
In our last basic science seminar, Drs. Caldwell, Neher and Hamilton Smith
dealt with the ultrastructure of the nephron which constituted a fitting introduction
to our consideration this afternoon of the experimental and clinical aspects of
nephrosis. Nephrosis is a systemic disease with disturbances in many a.reas of
metabolism. In the broad sense of the word, there are many causes of the clinical
syndrome we call nephrosis. These have been reviewed at length by Adams^ in his
excellent monograph. For the present seminar, however, we shall confine our discussion to consideration of a clinical entity characterized by proteinuria, hypoproteinemia and hyperlipemia. In the pediatric age group, this syndrome often is
associated with one of four diseases: acute glomerulonephritis, it may occur during
the course of chronic glomerulonephritis, it may be seen as a sequel to SchonleinHenoch Purpura (historically more correctiy referred to as Heberden's Purpura^) and
it may occur as a familial disease. It is referred to variously as nephrosis, childhood
nephrosis, or lipoid nephrosis. It is sometimes regarded as occurring in "pure" or
"mixed" varieties.
Inasmuch as a major clinical manifestation of this disease consists of massive
proteinuria and associated hypoproteinemia, we will ask Dr. O'Neill to deal with
the disturbances seen in protein metabolism.
DR. O'NEILL
Nephrosis is a distinct clinical and biochemical entity. It is characterized by:
edema, proteinuria, hypoproteinemia and hyperlipemia. Occasionally one sees hematuria, hypertension or azotemia. The pathogenesis of nephrosis is unknown, but it
is commonly thought to be the result of an antibody reaction to unknown stimuli in
a susceptible person.
While the causes of the disease in children are somewhat limited, in older age
groups other causes are seen:
1. Intrinsic renal disease
a. Membranous glomerulonephritis
b. Mixed glomerulonephritis
2. Infection
a. Syphilis
b. Malaria
3. Poisons
a. Heavy metals
b. Organic solvents
c. Drugs
* Basic Science Seminar presented at the Henry Ford Hospital by the Deparmtent of Pediatrics,
October 24, 1960.
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4. Hypersensitivity reactions
a. Insect stings
b. Serum sickness
c. "Anaphylactoid" purpura
5. Mechanical
a. Renal vein thrombosis
b. Pericarditis
c. Tricuspid insufficiency
6. Systemic disease
a. Systemic lupus erythematosus
b. Amyloidosis
c. Multiple Myeloma
d. Diabetes mellitus
7. Heredofamilial Nephrosis
Historically, "classical nephrosis" or membranous nephrosis, studied by light
microscopy showed lipoid tubular degeneration, occasional increased cellularity of
the glomerulus and splitting of the basement membrane. The lipoid granules in
the tubules were considered the primary lesions of nephrosis. Actually, the lipoid
granules of the tubules are the result of reabsorption of lipids that are the product
of abnormal glomerular function rather than the primary defect in the disease.
Elucidation of the primary lesion had to wait until the studies of the normal
glomerulus were done by electron microscopy. Agreement on the histology of the
glomerulus was no small struggle. Due to different staining techniques, artifacts
and studies of various sections of the glomerulus, there was much controversy over
normal glomerular histology. Now it is pretty well agreed that there are three layers
in the normal glomerulus; endothelium, basement membrane and epithelium
with podocytes. Farquhar, Vernier and Good^ studied sections of the kidney from
patients with various primary diseases having in common the presence of nephrosis.
One lesion, other than the changes of the primary disease process, common in the
glomeruli was the presence of degenerative changes in the podocytes. This lesion
seems related quantitively to the severity of proteinuria. With the healing of the
podocytes, proteinuria decreases. Hall" has proposed that the spaces or pores between
the podocytes normally limit the molecular size of glomerular filtrate and that
podocyte changes allowed larger protein particles to pass through and be lost in
urine. Others have taken exception to this, postulating that it is not just a geometrical
problem of pore size, but rather that there exists an enzymatic aspect to glomerular
permeability and upon degeneration of the podocytes, there exists a biochemical
defect allowing large protein particles to pass.
Before discussing the pathophysiology of nephrosis, a few comments as to age
incidence of onset may be of interest. Acute glomerulonephritis has its highest
incidence between four to ten years of age with a peak at about six to eight years.
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Nephrosis has its highest incidence from six months to six years with a peak of
about 18 to 30 months. An episode of acute upper respiratory infection or acute
tonsillitis is found to precede acute glomerulonephritis by two weeks in about 60 to
80 percent of cases, but in nephrosis this occurs only in 25 to 30 percent of cases
Some workers have suggested that infection is related to the onset of obvious edema
in nephrotic patients only in that infection produces water retention in any child.
However, in the yet unrecognized nephrotic child with inapparent edema, the added
insult of infection may make the patient's nephrotic edema apparent for the first
time. About 40 percent of nephrotics have a past history or family history of allergy,
while this is much lower in the patients with acute glomerulonephritis.
Turning to the pathogenesis of nephrosis, two general views exist in regard to
the primary defect; first, that nephrosis is a primary renal disease, more specifically
a disorder of the epithelial podocytes. The second view is that nephrosis is a
generalized metabolic disease with glomerular lesions being but a part of the process.
The second view seemed a little vague until many excellent observations of a generalized capillary, metabolic, immunological, electrolyte, and hormonal disturbances of
nephrosis are reviewed, then the theory of a systemic disease existing seems more
logical. Without defending or trying to propagate any given viewpoint, let us try
to evaluate each theory objectively.
Proteinuria is one of the most striking findings in nephrosis and may reach 20
to 60 grams per day. Proteinuria could be due to excretion of an abnormal protein,
reduced tubular reabsorption of normally filtered proteins, or increased glomerular
filtration. Immunological, chemical, and electrophoretic studies of urinary proteins
rule out the first theory of abnormal portein production. The proteins excreted are
normal serum albumin and globulins. Regarding the second theory, if 30 to 40
percent of serum proteins normally filtered by the glomerulus were not absorbed,
one could account for all of the albuminuria. However, tubular reabsorption studies
of albumin in normal and nephrotic patients is about equal. Microcannulation and
Evan's Blue dye studies on experimental animals also confirmed the fact that protein
absorption in normal and nephrotic animals was about equal. A third theory is
that of increased glomerular permeability to serum protein. By micropuncture techniques, it has been shown that nephrotic kidneys have increased protein clearance.
In human studies, infusion of nephrotic patients with dextran particles of molecular
weights of from 10,000 to 150,000 with simultaneous fusion of tagged albumin and
globulin, it has been shown that the dextrans of the molecular size of the various
serum albumin and globulin molecules have been excreted in equal proportion to
the concentration of albumin and globulin present. To add more support to this
theory of increased glomerular permeability, one would expect the large molecules
to pass less easily and the smaller molecules to pass more easily. This is borne out
by the fact that the larger globulin molecules are found in lower concentration in
the urine.
The source of the amount of proteins lost in the urine by the nephrotic patients
is controversial in regard to the symptomalogy and total body nitrogen balance.
Metabolic balance studies in nephrosis in the active stage showed markedly negative
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nitrogen balance. However, such patients synthesize two to five times the usual
amount of albumin and globulins; the total turnover of serum proteins is therefore
greatly exaggerated. This has also been demonstrated with the use of albumin
tagged with Lm and tagged glycine molecules. The net result of proteinuria and
greatly increased protein synthesis is reflected in serum by a low albumin, low alpha
I gamma globulin, and low metal carrying globulins. Globulins of larger molecular
size, the beta lipoglobulins and the alpha I lipoglobulins, due to an increased rate
of synthesis and a decreased or at least not a very high rate of excretion, are
actually increased in nephrosis, accounting for part of the hyperiipemia. Along with
low beta lipoglobulin levels, one sees a low serum iron, low serum copper and
low iron binding capacity. The protein-bound iodine is excreted in large amounts
resulting in a low serum protein bound iodine value. However, normal I-13, uptake is
present, excluding hypothyroidism as a factor in nephrosis. Gamma globulin synthesis
is markedly increased and so is gamma globulin excretion; the net result is that the
nephrotic usually has a very low gamma globulin. The role of protein intake on
overall mortality is difficult to evaluate, but Blainey' and others have shown straight
line correlations between nitrogen intake and storage. It is not possible to predict
on the basis of patients' nitrogen balance whether or not recovery will occur.
DR. MANSON
No disturbance of metabolism in nephrosis is independent of other metabolic
pathways. This is cleariy illustrated by the observation that the infusion of 50 grams
of salt-free human albumin is generally completely lost by the kidney within 24 to
72 hours from the time of infusion. Thus, albumin infusion is of more value to
the physician's peace of mind than to the patient's nephrosis. An interesting observation in this regard is that such an infusion tends to produce a concomitant transitory
decrease and subsequent rise in serum cholesterol level. Moreover, we note that in
the nephrotic patient on steroid therapy, one generally must achieve a rise in serum
albumin before the serum lipid level tends to fall. For a discussion of lipid metabolism
and some of its inter-relationships with protein metabolism we shall hear Dr. Bandera.
DR. BANDERA
One of the metabolic disturbances found in nephrosis is hyperlipemia; the extent
of the total lipids infrequently may reach a level of five grams. Although many of the
metabolic inter-relationships of lipid and protein metabolism are known, an adequate
explanation for the hyperlipemia has not yet been established.
In aqueous medium; that is, serum, lipids exist as joined colloidal lipid-protein
complexes known as lipo-proteins. When the serum is analyzed electrophoretically,
lipo-proteins are grouped into two fractions: (1) Alpha lipoproteins which are of
lower molecular weight, high density, low lipid content lipo-proteins and (2) Beta
lipoproteins which are high molecular weight, high lipid content lipo-proteins. Beta
lipo-proteins normally transport about 70 percent of all plasma lipids in a normal
fasting person. The fate of lipids in body fluids could be told in this simplified way:
in the succus entericus the lipids exist as chylomicrons. Upon entering venous blood,
by action of "clearing factor"', there is loss of triglycerides from the chylomicrons and
the lipids are found as low density beta lipo-proteins. These in turn are transformed
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to high density alpha or beta hpo-proteins. The "clearing factor" is thought to be
a Upo-protein lipase. The following factors are thought to influence the activity or
effectiveness of lipo-protein lipase; heparin, plasma proteins, and "tissue factor."
In trying to explain the hyperlipemia of the nephrotic serum, certain observations
are useful. Although it is established that infusion of plasma protein will decrease
the hyperlipemia of the nephrotic sera, the infusion of plasma protein has no effect
on normal plasma systems. There is no diminution of lipemia. In experimental nephrosis,
hyperiipemia precedes the diminution of serum proteins. Another pertinant observation
is that in idiopathic hypoalbuminemia, serum lipids are normal but one can diminish
serum lipids with infusion of albumin.
It is known that heparin will clear the lactescent nephrotic serum.' At least in
certain experimental situations it has been established that the degradation of heparin
is not increased. When heparin is injected into nephrotic rats and the rat's serum
titrated with protamine sulfate, the prolongation of clotting time is similar in nephrotic
serum as compared with normal control. Infusion of heparin to nephrotic rats with
hyperiipemia does not diminish the extent of their hyperhpemia. These observations
would exclude heparin, or lack of it, as the sole cause of hyperiipemia.
Despite low protein bound iodine and basal metabolic rate values in nephrotic
patients, there is no evidence to suggest that the nephrotic patients are hypometabolic.
The hyperiipemia of the nephrosis, although similar to that found in hypothyroidism
cannot be influenced by the administration of thyroid extract. Marsh and Drabkin'
have proposed a very interesting theory of hyperiipemia. They suggested that in nephrosis
the body's main and most important effort must be to regenerate serum proteins lost
in the urine. Since proteins are excluded from the metabolic functions they would
normally participate in, such as gluconeogenesis, fats are called upon to carry the
metabolic burden. Thus, the picture that one sees in nephrosis might represent mobilization of body lipid stores and the increased quantity in serum reflect an increased
demand for them in the metabolic economy of the body. This situation could be
rightly called "lipid diabetes."
The role of albumin in the hyperlipemia of nephrosis cannot be overiooked.
Although it is thought that albumin serves as a 'carrying horse" for serum lipids, it is
unlikely that its function is that simple. In this connection, the observation that the
hyperiipemia persists despite the correction of serum albumin, as seen in clinical
remission, supports the impression that there are other factors operating in the disturbances of lipid metabolism in the nephrotic patient. It is thus pertinent to remember
that in acute glomerulonephritis, one sees hyperiipemia with normal serum proteins.
The question of what constitutes the "clearing factor" cannot be answered as yet.
DR.

MANSON
Disturbances in protein metabolism with their inevitable consequences in the area
of lipoid metabolism also have a rather direct bearing on electrolyte and water
metaboUsm. From the patient's point of view, edema may be his most distressing
clinical manifestation. Edema formation, however, is not simply a matter of hypoproteinemia but also involves certain other factors. Dr. O'Neill will discuss these
factors.
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O'NEILL

Edema is one of the major clinical findings of nephrosis and to parents this is
one of the most distressing, ominous signs encountered. The clinician, however, must
keep in mind that massive edema of nephrosis is but a reflection of many metabolic
processes going on simultaneously to produce the net result — edema. Many factors
operate to produce edema in any disease; in nephrosis, low protein, hormonal disturbances, water and electrolyte derangements contribute to the production of edema.
Low protein is a result of increased protein catabolism and urinary loss. However, in
other diseases with equally low serum protein concentrations, one does not see the
massive edema of nephrosis; therefore, there must be other factors. Nephrotic patients
have diminished plasma volume and occasionally this results in decreased renal blood
flow with a shock-like picture which could account for edema on the basis of renal
failure. However, this would not explain all cases of massive edema. Another possibility
is the increased amount of antidiuretic hormone that has been found in nephrotic
patients. This, however, is not a constant finding and could not explain all the cases
of edema. In 1953 British investigators' observed that various extracts of urine
from nephrotic patients showed marked sodium retaining activity and produced
a potassium diuresis. These urinary extracts caused changes similar to those produced
by crude adrenal extract; the active compound being later identified as aldosterone.
This compound is present in increased quantities in nephrotic patients and is believed
to play a large part in the often massive edema of nephrosis accompanied by extreme
sodium and water retention and potassium excretion. The nephrotic patient can tolerate
much larger excretory loads of potassium than the normal person but does not tolerate
sodium and water as well. However, a major mistake made in treating nephrosis is to
assume that limitation of sodium is essential to prevent edema. It is true that limiting
sodium intake to some extent is necessary; however, a nephrotic patient seems to have
a certain threshold level of edema which is the sum total of the hormonal and protein
factors. When given more salt, the patient will increase his threshold for edema but
beyond that point any excess salt is excreted. In treating nephrosis, acute limiting
of sodium and the misery it causes these children, is certainly inexcusable on the
basis of metabolic studies. Moreover significant sodium restriction is impossible, if
good nutrition is to be provided. The mechanism for increased aldosterone production
is probably on a basis of low plasma volume and as the sodium is diluted by the edema
from other causes, osmo-receptors stimulate aldosterone production causing more sodium
retention. Hydrocortisone will cause a rapid drop in aldosterone levels and the interesting observation is that in a spontaneous or induced remission, one sees a marked
drop in aldosterone before diuresis occurs. One other possibility in nephrotic edema
has been studied, that of generalized capillary permeability. Perfusion with Evans
Blue tagged albumin substantiates the idea that, not only do glomerular capillaries
have increased permeability, but the capillaries in other parts of the body as well.
The actual quantitation of this phenomenon as to particle size has been very difficult,
but there is clear indication that at least in part, the edema of nephrosis is due to
generalized increased capillary permeability.

DR.

BANDERA
As a clinical "rule of thumb," it is usually accepted that edema will appear when
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the serum albumin in an adult falls to a level of 2.5 grams percent or less; or in a
child under 10 years of age, the serum albumin level reaches 1.2 grams percent. In
nephrotic patients, however, one often sees no discernable edema when the serum
albumin is less than 1 gram percent. The analysis of the tissue specimens of edematous
rats shows that the skin and subcutaneous tissues are the most avid acceptors of water.
An excess of 1.9 grams of water per gram of tissue is retained in a nephrotic rat's skin.
One gram of muscle tissue of a nephrotic rat has an excess of 0.5 grams of water as
compared to the tissue of a normal rat. The analysis of electrolytes of a nephrotic rat's
tissue shows that there is marked increase in sodium and chloride and decrease in
potassium content when compared to the tissue of healthy rats.
DR. MANSON
So we see that a number of metabolic disturbances are involved in the clinical
picture we know as nephrosis. These aberrations have been rather well worked out
to date. Much work has been done and much remains to be done in elucidating the
basic reason of why these disturbances occur. This brings us then to a consideration
of experimental nephrosis and nephritis and the relationship of these experimental
models to human disease. For this we shall call on Dr. Bandera.
DR. BANDERA
Experimentally, one can produce in animals a whole spectrum of renal diseases.
These range from lesions clinically resembling human acute glomerulonephritis, to
lesions resembling nephrosis and serum sickness. Many agents have been used: aminonucleosides, nephrotoxic sera, intravenous saccharated ferrous oxide, trimethadione,
just to mention a few. From these studies much knowledge has accumulated.
Our correlation of anatomical lesions and clinical picture has become clearer; the
biochemical aberrations and their sequence of appearance, inter-relationship and pathogenesis has been intensively investigated. Although the crowning of these experimental
investigations would be definition of etiology (or etiologies) of human nephrosis, the
fact that some renal lesions experimentally produced so closely resemble human
nephrotic syndrome helps us to understand and manage the patients with the disease.
It has been cleariy established that, at least in the rats, nephrosis and nephritis can
be diseases of hypersensitivity. Some investigators have followed a different path
of investigation. They have been able to produce experimental nephrosis with subcutaneous injections of an amino-nucleoside, 6-dimethylamine-9 purine. This experimental approach has been studied by Bartlett at this hospital."
It has been
shown by experiments using mitochondria prepared from pooled kidney tissue that
there is a loss of mitochondrial activity in respect to both substrate oxidation, and
concomitant phosphorylation, when succinate is used as a substrate. The following
sequence of histologic changes has been established in experimentally produced
nephrosis. Within one hour after administration of nephrotoxic sera to experimental
animals, there occurs swelling of foot processes and increase in the amount of epithelial
cytoplasm. In three hours swelling of epithehal cells takes place and in six hours there
is coalescence of foot process. By 24 hours one finds proteinuria and the clinical
picture of nephrosis follows soon after that. Amino-nucleoside induced nephrosis is
somewhat different: the rat is the only susceptible animal. Although one is able to
produce a full-blown picture of nephrosis with elevation of the B U N with this
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agent, upon the discontinuation of amino-nucleoside induced nephrosis appears on the
sixth day, edema and ascites appears on the tenth day, and uremia on the twelflh day.
The main histologic change, which is somewhat different than in "hypersensitivity"
nephrosis, is vacuolization of mitochondria within the distal tubules and breaking
up of cristae.
Not only has production of experimental nephrosis been extensively investigated,
but the modification and prevention of the disease has produced some interesting results.
For instance, total body radiation, cortisone in a dose of 5 mg. per kilogram per day
will produce significant suppression of disease. Marked or complete suppression can
be attained by giving cortison in a dosage of 20 mg. per kilogram per day. Nitrogen
mustards given in adequate doses will also prevent production of nephrosis by the
use of nephrotoxic sera. It is significant that all these agents; radiation, steroids and
nitrogen mustards are agents which we associate with inhibition of immunologic systems.
In this connection it is worth pointing out that amino-nucleoside nephrosis is not
influenced by pre-treatment with steroids.
The immunologic concept is frequently chaflenged by the fact that infants, who
are usually considered "immunologically immature," will develop nephrosis. In this
connection, it is worth pointing out that maternal antibodies against infants' kidneys
have not been foimd.
Certain questions might be raised regarding the relationship of experimental
nephrosis to the clinical nephrosis: a. Is there an abnormal nucleoside or nucleotide
which functions as an antimetabolite and inhibits renal enzyme systems? b. Is there
a "substance" which might be a by-product of an antigen antibody reaction which is
responsible for the clinical picture of nephrosis? Although in azotemic patients abnormally high levels of nucleotides have been found, the relationship of those substances
to nephrosis has not been established.
DR.

MANSON

The possible role of the immune mechanism in the production of human nephrosis
has been long apparent. Further substantiation of this concept has been emphasized
by the discussion of experimental nephrosis by Dr. Bandera.
Clinically, it has been noted that atopic allergy is more common in families of
nephrotic patients than in normal controls. Eosinophilia in these patients is not infrequent. It is equally clear, however, that atopic allergy together with a positive family
history, hardly provides an adequate explanation of the pathogenesis of the disease.
Other evidence of the role of the immune mechanism in this disease is to be found in
the observation that complement is diminished in these patients. Serum complement
also falls in experimental nephrosis. Furthermore, it has been demonstrated that this
reduction in serum complement in both situations is not due to urinary loss in a manner
analogous to serum iron, .serum copper, protein-bound iodine, etc., as discussed previously. Localization of antibodies on glomerular components has been demonstrated
in experimental disease but this observation has not been made in specimens from
human nephrotic patients. However, in experimental disease these antibodies may
remain attached to the glomerulus for months.
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Antibodies to human kidney tissue have been studied but their presence in
nephrotic patients has not been consistentiy demonstrated and the observation is open
to considerable question. Boyden" has studied the sera of nephrotic patients by
means of her tanned red blood cell technique. She reported that the sera of nephrotic
patients produced agglutination of these specially treated red cells and showed that
steroid therapy prevents this response. Other workers, however, have been unable
to duplicate these results and so this observation remains open to some question.
Occasional isolated case reports of nephrosis in early infancy have been interpreted by some to imply that the immune mechanism is not as important as some have
suegested inasmuch as the young infant is regarded as an immunologically immature
individiual. Though this is in general true, it should be remembered that the immune
response of young infants to test antigens is a complex problem because of the influence
of passive maternal immunity to a wide variety of antigens. Furthermore, young infants
may show a striking response to some antigens when maternal titers to these antigens
are low.
In any event, similarities between human nephrosis and experimental immunologic
disease are sufficient in number and nature to provide a rationale for the ablation
of such a pathogenetic response by the use of steroid therapy. It might be pointed out
in this regard that, utilizing the same rationale, nitrogen mustards have been used for
the same purpose in the role of antireticuloendothelial agents." We shall ask Dr. Bandera
to discuss the present day therapeutic approaches to nephrosis.
DR. BANDERA
In planning a therapeutic regimen there are some considerations which influence
the therapeutic success of a regimen. It has been found that in the case of nephrotic
patients less than one year of age, the disease is usually not influenced by any therapeutic
regimen. The duration of the disease has bearing on the responsiveness; the purity of
clinical picture is rather important since, if one has complications such as positive
tubercuHn reaction or exposure to tuberculosis, prolonged disease with impaired renal
function, or hypertension the approach is somewhat different.
Historically, one is impressed by the great mortahty of nephrotic patients in the
pre-antibiotic era. Barnes, et. al.," in 1950 reported 42% of patients out of his series
of 107 patients died when followed two or more years. Although antibiotic therapy
lessened the mortality, the survival figure still left much to be desired.
Many articles have been written on efficacy of steroids or corticotropin and the
clinical course of nephrosis. Most articles have reported favorable infiuence on the
course of the disease and very little influence on the growth if the steroids are used
intermittentiy." Some investigators feel that corticotropin is the preparation to use;
others have praised one steroid in preferance to another as far as the side effects,
hypertension and the percentage of remissions is concerned. Certain serious side
effects of steroid therapy have been seen in nephrotic patients. Consensus, however,
is that steroids should be used intensively and not merely as diuretic agents to be
stopped as soon as diuresis ensues, but to be continued until the biochemical abnormalities, hypoalbuminemia and albuminuria, disappear and there is a cessation
of hyperlipemia.
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Some investigators" report chlorothiazide will produce substantial diuresis. Threshold substances, such as Vitamin C, are occasionally used to induce diuresis. Although
albumin will frequently produce temporary diuresis, it is worth pointing out that the
pre-infusion level is usually reached within 24 to 72 hours and the course of the
disease is not influenced by any such infusion even repeated daily. When after an
adequate trial of steroids or corticotropin no response is obtained, frequently the nitrogen
mustards are used with some success. In a resistant case one can use spirolactones, but
our experience in this phase of treatment has been limited. Although steroids are
thought to be rather specific, there are reports that nephrosis will return after
remission of four years or more when the steroids are discontinued."
One should not forget that supportive treatment such as adequate diet, reasonable
isolation, and prevention of exposure to infections, especially viral, should be practiced
when the patient is on high doses of steroids. Antibiotics, of course, do not influence
the course of nephrosis but antibiotic treatment of bacterial infections has markedly
reduced mortality from that major cause. Some also consider it good taste to put
the patient on "prophylactic" antibiotics when long term steroid treatment is employed. This practice is open to serious question" and we no longer follow it in this
clinic.
One should keep in mind that nephrosis is not the only thing that we are concerned
with: the family, their attitude toward the manifestation of the disease, such as edema,
profoundly influence our approach to it. Parents are often disturbed by the acneiform
eruption or moon-face of the steroid treated patient. It is hard for them to accept
that more than appearance is at stake when the patient is receiving steroids. Sympathy
and an understanding attitude, combined with adequate explanation of what one is
aiming at frequently is enough to change the parents' attitudes toward the disease, our
management and the child's acceptance of necessary hospitalization and unpleasant
venipuncture. In this regard, we must acknowledge the blessings of microchemical
technics. The frequent criticism that we have no controls for the present regimen of
steroid therapy is eloquently rebutted by the observation that our controls were all
buried before the dawn of antibiotic therapy and may probably be used as an indication
of the effectiveness of therapeutic antibiotics together with long term steroid therapy."
DR.

MANSON

Thank you. Dr. Bandera and Dr. O'Neill. Our time is drawing to a close and before
it is up, I should like to emphasize a few points on which I think we all agree. The
first is that nephrosis in childhood is a disease of unknown etiology whose prognosis
has been vastly improved by two well established forms of therapy. It has been stated
that with the use of antibiotics to treat bacterial infections, 40-60% of nephrotic
children will ultimately recover. Most observers are of the opinion that with the use
of adequate steroid therapy, as many as 70-80% of such patients will recover.'
Secondly, if steroid therapy is to be used, and we feel strongly that it should be, these
agents should be used in large enough doses for a long enough period of time. It has
been established that adequate steroid therapy will reverse the abnormalities of the
podocytes which are found on electron microscopy of needle biopsy specimens of
the kidney from affected children and produce clinical remission. Thus we have
objective evidence of the value of corticoid therapy in this difficult disease of childhood.
348

Nephrosis
In our clinic, we have followed a prescribed program of treatment, in conjunction
with the Children's Hospital of Michigan and the Department of Pediatrics and Communicable Diseases of the University Hospitals at Ann Arbor, which is part of a
national study, designed to evaluate the long term results of therapy in this disease."
The fact that this study involves three institutions in the same corner of Michigan
brings me to the third point on which we find agreement. Nephrosis is a disease which
taxes the patience and confidence of parents and physician alike because of its natural
history of remissions and exacerbations and its chronicity . . . the average case
lasting two to three years, sometimes longer. The tendency is strong for parents of
affected children to seek help at one institution and then another. This is clearly shown
by comparing the rosters of nephrotic patients at one center with the other two.
However, by a joint effort of the three hospitals involved, we have obtained a good
follow-up on virtually all of the nephrotic children in this area for the past several
years. The results obtained to date are presentiy under study and the project continues.
The fact that nephrosis is such a trying disease to treat, brings into bold relief the
importance of ancillary measures in the management of the patient. These include:
orientation of the parents regarding nephrosis; prompt treatment of bacterial infections
when they occur; minimizing exposure to infection, both bacterial and viral; education
for the patient; maintenance of nutrition, especially insuring that the child gets as
much protein food as possible; appreciation of the fact that steroid therapy is not
without risk and careful evaluation of steroid induced complications when they occur,
bearing in mind that nephrosis is a serious disease in which the side effects of steroid
therapy must often be balanced against the implications of the disease.
Thank you gentiemen — we stand adjourned.

REFERENCES
1. Adams, D. A.: Pathophysiology of the nephrotic syndrome. Arch. Int. Med. 106:117, 1960.
2. Rook, A.: WiUiam Heberden's cases of anaphylactoid purpura. Arch Dis. Childhood
33:271, 1958.
3. Vernier, R. L., Farquhar, M . G., Brunson, J. G., and Good, R. A.: Chronic renal disease
m children, A.M.A. J. Dis. Child. 96:306, 1958.
4. Hall, B. 'V.: Studies of normal glomerular structure by electron microscopy. In, Proceedings
of the Fifth Annual Conference on the Nephrotic Syndrome, New York, National Nephrosis Foundation, Inc., 1953, p. 1.
5. Blainey, J. D.: High protein diets in the treatment of nephrotic syndrome, Clin. Sc.
13:567, 1954.
6. Rosenman, R. H., Friedman, M . , and Byers, S. O.: The causal role of plasma albumin
deficiency in experimental nephrotic hyperlipema and hypercholesteremia, J. Clin. Invest. 35:522, 1956.
7. Gitlin, D., Cornwell, D. G., Nakasato, D., Oncley, J. L., Hughes, W. L., Jr., and Janeway,
C. A.: Studies on the metabolism of plasma proteins in the nephrotic syndrome. I I . The lipoproteins, J. Clin. Invest. 37:172, 1958.
8. Marsh, J. B., and Drabkin, D. L.: Metabolic channeling in experimental nephrosis, lipide
metabolism, J. BioL Chem. 212:633, 1955.
9. Simpson, S. A., and Tait, J. F.: Physico-chemical n-.ethods of detection of a previously
unidentified adrenal hormone. In, Society for Endocrinology: Conference on Determination of
Adrenocortical Steroids and their Metabolites, 1953. Ed. by P. Eckstein and S. Zukerman, London,
Dobson, 1953, p. 9.

349

Bandera, O'Neill and Manson
10. a. Bartlett, P., and Shelata, S.: Mechanism of aminonucleoside-nephrosis in the rat. I .
MetaboUsm of tritiated aminonucleoside. Proc. Soc. Exper. Biol. & Med. 102:499, 1959^
b. Bartlett, P., and Ford, L.: Studies on the mechanism of aminonucleoside-induced
nephrosis in the rat. I I . Oxidative-phosphorylation, Fed. Proc. 19:38, 1960.
c. BarUett, P., and Ford, L.: Studies on the mechanism of aminonucleoside-induced
nephrosis in the rat. I I I . Metabolism of aminonucleoside-S-C", Proc. Canadian Fed
3:8, 1960.
d. Bartlett, P., and Shaefer, H.: Observations on mitochondrial oxidative phosphorylation
and swelling during induction of aminonucleoside-nephrosis in the rat Fed Proc
20:48, 1961.
11. Boyden, S. 'V.: Adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera, J. Exper. Med. 93:107, 1951.
12. West, C. D.: Use of combined hormone and mechlorethamine (Nitrogen mustard) therapy
in lipoid nephrosis, A.M.A.J. Dis. Child. 95:498, 1958.
13. Barness, L. A., Moll, G. H., and Janew.ay, C. A.: Nephrotic syndrome: natural history
of the disease. Pediatrics 5:486, 1950.
14. Lange, K., Wasserman, E., and Slobody, L. B.: Prolonged intermittent steroid therapy
for nephrosis in children and adults, J.A.M.A. 168:377, 1958.
15. Schreiner, G. E.: Chlorathiazide in nephrosis. In, Proceedings of the Ninth Annual Conference on the Nephrotic Syndrome, New York, National Nephrosis Foundation Inc., 1958, p. 177.
16. Worthen, H.: Relapse after prolonged remission. In, Proceedings of the Tenth Annual
Conference on the Nephrotic Syndrome, New York, The National Kidney Disease Foundation
1959, p. 268.
^
17. Gibbs, R. C , Biro, L., and Sulzberger, M . B.: Prophylactic administration of antibiotics
in patients receiving steroids systemically, J.A.M.A. 172:61, 1960.
18. Johnston, J. A.: Unpublished data.
19. Hinchman, D. F.: The nephrotic syndrome, Henry Ford Hosp. M . Bull. 5:31, 1957.

350

